These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 36122809)

  • 1. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
    Britch SC; Craft RM
    J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
    Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
    J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaporized cannabis extract-induced antinociception in male vs female rats with persistent inflammatory pain.
    Craft RM; Gogulski HY; Freels TG; Glodosky NC; McLaughlin RJ
    Pain; 2023 Sep; 164(9):2036-2047. PubMed ID: 37027147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
    Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
    Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
    Britch SC; Craft RM
    Behav Pharmacol; 2021 Dec; 32(8):630-639. PubMed ID: 34561365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
    Craft RM; Kandasamy R; Davis SM
    Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis constituent synergy in a mouse neuropathic pain model.
    Casey SL; Atwal N; Vaughan CW
    Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cannabidiolic acid and ∆
    Rock EM; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
    Moore CF; Weerts EM
    Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol-Δ
    Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
    Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol modulation of antinociceptive tolerance to Δ
    Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
    Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
    Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single and combined effects of Δ
    King KM; Myers AM; Soroka-Monzo AJ; Tuma RF; Tallarida RJ; Walker EA; Ward SJ
    Br J Pharmacol; 2017 Sep; 174(17):2832-2841. PubMed ID: 28548225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
    Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG
    Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.
    Carey LM; Maguire DR; France CP
    Drug Alcohol Depend; 2023 Mar; 244():109787. PubMed ID: 36753805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol Interferes with Establishment of Δ
    DeVuono MV; La Caprara O; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
    Cannabis Cannabinoid Res; 2022 Feb; 7(1):58-64. PubMed ID: 33998876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.